Name | Type | Posted | Actions |
|---|---|---|---|
Award Synopsis TRI.pdf | Dec 1, 2021 |
PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS
Contact and place of performance
Kishan Patel
Bethesda, MD 20817
USA
PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS
The National Institutes of Health has issued an award notice for solicitation number 75N93019R00023, which supports preclinical and translational vaccine development for HIV and other candidate agents. This initiative is classified under NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN12 for Health R&D Services; Health Care Services; Applied Research. The procurement utilized an SBP set-aside.
The primary place of performance for this contract is Bethesda, Maryland. Documented under the point of contact Kishan Patel, the notice includes one attachment titled Award Synopsis TRI.pdf, which was published on December 1, 2021. This award facilitates the advancement of vaccine candidates from the early research stages through the translational process to support public health objectives.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.